Acute Abdomen in Adults- a Prospective Study on Emergency Department Admissions
Launched by TAMPERE UNIVERSITY HOSPITAL · Mar 3, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying adults who come to the emergency department with abdominal pain. The main goal is to understand the different reasons why these patients are admitted and to see how many of them are initially sent home with a diagnosis of "non-specific abdominal pain" but later need to return because they are found to have a specific issue. This research will help improve how doctors evaluate and treat patients with abdominal pain.
If you are an adult aged 18 or older and have experienced abdominal pain, you may be eligible to participate in this study. Participants can expect to provide information about their symptoms and treatments during their visit to the emergency department. The study is currently recruiting participants, and it aims to gather valuable insights that could enhance patient care in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All adult patients with abdominal pain.
- Exclusion Criteria:
- • Under the age of 18 years
About Tampere University Hospital
Tampere University Hospital (TAYS) is a leading academic medical center in Finland, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, TAYS integrates cutting-edge medical practices with rigorous scientific investigation, focusing on improving patient outcomes and enhancing treatment modalities across various specialties. The hospital collaborates with a network of researchers, healthcare professionals, and academic institutions to foster a multidisciplinary approach to medical research, ensuring that findings are translated into real-world applications for the benefit of patients and the broader healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tampere, , Finland
Patients applied
Trial Officials
Satu-Liisa K Pauniaho, MD, PhD
Principal Investigator
Tampere University Hospital, Finland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials